11-17522838-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_153676.4(USH1C):c.965G>A(p.Arg322Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000147 in 1,613,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_153676.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH1C | NM_153676.4 | c.965G>A | p.Arg322Gln | missense_variant | 12/27 | ENST00000005226.12 | NP_710142.1 | |
USH1C | NM_005709.4 | c.965G>A | p.Arg322Gln | missense_variant | 12/21 | ENST00000318024.9 | NP_005700.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH1C | ENST00000005226.12 | c.965G>A | p.Arg322Gln | missense_variant | 12/27 | 5 | NM_153676.4 | ENSP00000005226 | ||
USH1C | ENST00000318024.9 | c.965G>A | p.Arg322Gln | missense_variant | 12/21 | 1 | NM_005709.4 | ENSP00000317018 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000725 AC: 18AN: 248408Hom.: 0 AF XY: 0.0000742 AC XY: 10AN XY: 134840
GnomAD4 exome AF: 0.000150 AC: 219AN: 1461464Hom.: 0 Cov.: 33 AF XY: 0.000160 AC XY: 116AN XY: 727044
GnomAD4 genome AF: 0.000125 AC: 19AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 20, 2015 | Variant classified as Uncertain Significance - Favor Benign. The p.Arg322Gln var iant in USH1C has been identified by our laboratory in one individual with heari ng loss who had an alternate explanation of the hearing loss identified (LMM unp ublished data). The p.Arg322Gln variant has also been identified in 9/63664 Euro pean chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadins titute.org; dbSNP rs140424216). The arginine (Arg) at position 322 is not conser ved through species, with star-nosed mole having a glutamine (Gln) at this posit ion, raising the possibility that this change may be tolerated. Additional compu tational prediction tools suggest that the p.Arg322Gln variant may not impact th e protein, though this information is not predictive enough to rule out pathogen icity. In summary, while the clinical significance of the p.Arg322Gln variant is uncertain, the lack of evolutionarily conservation suggests that it is more lik ely to be benign. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 01, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 322 of the USH1C protein (p.Arg322Gln). This variant is present in population databases (rs140424216, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with USH1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 166389). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Usher syndrome type 1C Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at